Caseware UK (AP4) 2023.0.135 2023.0.135 2023-06-302023-06-30false12022-07-01No description of principal activity1falsetrueThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006. 13442362 2022-07-01 2023-06-30 13442362 2021-06-07 2022-06-30 13442362 2023-06-30 13442362 2022-06-30 13442362 c:Director1 2022-07-01 2023-06-30 13442362 d:PlantMachinery 2022-07-01 2023-06-30 13442362 d:PlantMachinery 2023-06-30 13442362 d:PlantMachinery 2022-06-30 13442362 d:PlantMachinery d:OwnedOrFreeholdAssets 2022-07-01 2023-06-30 13442362 d:CurrentFinancialInstruments 2023-06-30 13442362 d:CurrentFinancialInstruments 2022-06-30 13442362 d:CurrentFinancialInstruments d:WithinOneYear 2023-06-30 13442362 d:CurrentFinancialInstruments d:WithinOneYear 2022-06-30 13442362 d:ShareCapital 2023-06-30 13442362 d:ShareCapital 2022-06-30 13442362 d:RetainedEarningsAccumulatedLosses 2023-06-30 13442362 d:RetainedEarningsAccumulatedLosses 2022-06-30 13442362 c:FRS102 2022-07-01 2023-06-30 13442362 c:AuditExempt-NoAccountantsReport 2022-07-01 2023-06-30 13442362 c:FullAccounts 2022-07-01 2023-06-30 13442362 c:PrivateLimitedCompanyLtd 2022-07-01 2023-06-30 13442362 e:PoundSterling 2022-07-01 2023-06-30 iso4217:GBP xbrli:pure

Registered number: 13442362










ESSENCE DERMATOLOGY LIMITED








UNAUDITED

FINANCIAL STATEMENTS

INFORMATION FOR FILING WITH THE REGISTRAR

FOR THE YEAR ENDED 30 JUNE 2023

 
ESSENCE DERMATOLOGY LIMITED
REGISTERED NUMBER: 13442362

STATEMENT OF FINANCIAL POSITION
AS AT 30 JUNE 2023

2023
2022
Note
£
£

Fixed assets
  

Tangible assets
 4 
724
1,004

  
724
1,004

Current assets
  

Debtors: amounts falling due within one year
 5 
8,272
4,674

Cash at bank and in hand
  
48,770
18,397

  
57,042
23,071

Creditors: amounts falling due within one year
 6 
(14,678)
(8,269)

Net current assets
  
 
 
42,364
 
 
14,802

Total assets less current liabilities
  
43,088
15,806

  

Net assets
  
43,088
15,806


Capital and reserves
  

Called up share capital 
  
1
1

Profit and loss account
  
43,087
15,805

  
43,088
15,806


The director considers that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the Year in question in accordance with section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The Company's financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the income statement in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf by: 




Page 1

 
ESSENCE DERMATOLOGY LIMITED
REGISTERED NUMBER: 13442362
    
STATEMENT OF FINANCIAL POSITION (CONTINUED)
AS AT 30 JUNE 2023

Dr O Golberg
Director

Date: 13 March 2024

The notes on pages 3 to 6 form part of these financial statements.

Page 2

 
ESSENCE DERMATOLOGY LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 JUNE 2023

1.


General information

Essence Dermatology Limited is a private company limited by shares and incorporated in England and Wales, registration number 13442362. The registered office is 27a Tylers Avenue, Billericay, England, CM12 0RA. 
                                                                                                                                                                                                                               The significant accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all years presented unless otherwise stated.
                                                                                                                                                                                                                   The financial statements are presented in sterling which is the functional currency of the company and rounded to the nearest £.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the Companies Act 2006.

The preparation of financial statements in compliance with FRS 102 requires the use of certain critical accounting estimates. It also requires management to exercise judgment in applying the Company's accounting policies.

The following principal accounting policies have been applied:

 
2.2

Revenue

Revenue is recognised to the extent that it is probable that the economic benefits will flow to the Company and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before revenue is recognised:

Rendering of services

Revenue from a contract to provide services is recognised in the period in which the services are provided in accordance with the stage of completion of the contract when all of the following conditions are satisfied:
the amount of revenue can be measured reliably;
it is probable that the Company will receive the consideration due under the contract;
the stage of completion of the contract at the end of the reporting period can be measured reliably; and
the costs incurred and the costs to complete the contract can be measured reliably.

Page 3

 
ESSENCE DERMATOLOGY LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 JUNE 2023

2.Accounting policies (continued)

 
2.3

Taxation

Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the Company operates and generates income.

 
2.4

Tangible fixed assets

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, using the straight-line method.

Depreciation is provided on the following basis:

Plant and machinery
-
25%
Straight Line

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss.

 
2.5

Debtors

Short-term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

 
2.6

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

 
2.7

Creditors

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

Page 4

 
ESSENCE DERMATOLOGY LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 JUNE 2023

2.Accounting policies (continued)

 
2.8

Dividends

Equity dividends are recognised when they become legally payable. Interim equity dividends are recognised when paid. Final equity dividends are recognised when approved by the shareholders at an annual general meeting.


3.


Employees

The average monthly number of employees, including the director, during the Year was as follows:


        2023
        2022
            No.
            No.







Directors
1
1


4.


Tangible fixed assets





Plant and machinery

£



Cost or valuation


At 1 July 2022
1,121



At 30 June 2023

1,121



Depreciation


At 1 July 2022
117


Charge for the Year on owned assets
280



At 30 June 2023

397



Net book value



At 30 June 2023
724



At 30 June 2022
1,004

Page 5

 
ESSENCE DERMATOLOGY LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 JUNE 2023

5.


Debtors

2023
2022
£
£


Trade debtors
6,514
4,674

Other debtors
360
-

Prepayments and accrued income
1,398
-

8,272
4,674



6.


Creditors: Amounts falling due within one year

2023
2022
£
£

Trade creditors
960
761

Corporation tax
11,366
3,393

Other creditors
352
2,315

Accruals and deferred income
2,000
1,800

14,678
8,269


 
Page 6